Haemonetics | HAE - Debt


Haemonetics reported $1.22B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Baxter International USD 9.69B 93M Mar/2026
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Boston Scientific USD 11.03B 407M Mar/2026
Cerus USD 84.16M 791K Dec/2024
Cooper Companies USD 2.46B 39.5M Mar/2026
Fresenius EUR 11.9B 28M Mar/2026
Fresenius Medical Care EUR 10.96B 66.06M Jun/2026
Globus Medical USD 115.22M 3.43M Mar/2026
Haemonetics USD 1.22B 153K Mar/2026
ICU Medical USD 1.23B 94.6M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
Medtronic USD 28.15B 192M Jun/2026
Merit Medical Systems USD 821.56M 9K Mar/2026
Neogen USD 793.3M 374K Dec/2025
OraSure Technologies USD 782K 465K Jun/2024
Plus Therapeutics USD 3.98M 372K Dec/2023
Quidel USD 2.87B 40.8M Mar/2026
ResMed USD 843.17M 4.55M Mar/2026
STAAR Surgical USD 37.29M 1.06M Mar/2026
Steris USD 2.09B 33.5M Mar/2026
Stryker USD 14.19B 32M Jun/2026
Teleflex USD 2.69B 39.95M Mar/2026
Terumo JPY 379.8B 219.92B Mar/2026
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
US Physical Therapy USD 220.02M 15.18M Jun/2026
Zimmer Biomet Holdings USD 7.48B 8M Jun/2026